Biotech Group Acquisition Corporation (BGAC)

Biotech Group Acquisition will go public soon, but the exact IPO date is still unknown.
IPO Price
$10.00
Shares Offered
7,500,000
Deal Size
$75.00M
Chart not available yet
Data will show when the stock starts trading.
Market Cap 98.72M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 9.87M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About BGAC

Biotech Group Acquisition Corporation is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to leverage the knowledge, expertise, capabilities and deep industry relationships of our management team and board of directors to focus on biotechnology companies with the potential to capitalize on the growing biotechnology sector in North America and the Asia-Pacific region (... [Read more]

Industry Shell Companies
Sector Financials
Founded 2022
Country United States
Stock Exchange NASDAQ
Ticker Symbol BGAC
Full Company Profile

News

Biotech Group Acquisition IPO Registration Document (S-1)

Biotech Group Acquisition has filed to go public with an IPO on the NASDAQ.

10 months ago - SEC